Citius Oncology (CTOR) Free Cash Flow (2023 - 2026)

Citius Oncology's Free Cash Flow history runs 4 years deep, the most recent figure standing at -$3.8 million for Q1 2026.

• In Q1 2026, Free Cash Flow changed N/A year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 2955.55% YoY), while the FY2025 annual figure was -$5.5 million, down 4446.59% from the prior year.
• Free Cash Flow was -$3.8 million for Q1 2026 at Citius Oncology, up from -$7.4 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$100256.0 in Q2 2023 to a low of -$7.4 million in Q4 2025.
• Historically, Free Cash Flow has averaged -$1.8 million across 4 years, with a median of -$366106.0 in 2024.
• Biggest YoY gain for Free Cash Flow was 13.56% in 2024; the steepest drop was 265.17% in 2024.
• A 4-year view of Free Cash Flow shows it stood at -$382527.0 in 2023, then increased by 4.29% to -$366106.0 in 2024, then sank by 1908.97% to -$7.4 million in 2025, then jumped by 47.9% to -$3.8 million in 2026.
• The last three Free Cash Flow figures came in at -$3.8 million (Q1 2026), -$7.4 million (Q4 2025), and -$366106.0 (Q2 2024), per Business Quant data.